ATP binding cassette transporter activator (Limerick)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameATP binding cassette transporter activator (Limerick)
Drug Alias Namemetabolic disorders therapy (Limerick)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATP-binding cassette transporter stimulants
TargetsATP-binding cassette transporter
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLimerick Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLimerick Biopharma Inc
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A